Location History:
- Indianapolis, IN (US) (1992 - 1994)
- San Diego, CA (US) (2011)
- Lincoln, NE (US) (2006 - 2013)
Company Filing History:
7 out of 164 
5 out of 769 
1 out of 38 
Years Active: 1992-2013
Title: David R Hathaway: Innovator in Cardiac and Reproductive Health
Introduction
David R Hathaway is a prominent inventor based in Lincoln, NE (US), known for his significant contributions to medical science. With a total of 12 patents to his name, Hathaway has focused on developing innovative treatments for various health conditions, particularly in the fields of cardiology and reproductive health.
Latest Patents
Hathaway's latest patents include groundbreaking work on the treatment of cardiac arrhythmias. His inventions involve compositions that include compounds binding to receptors for glucagon-like peptide-1 (GLP-1) and related agonists. These compounds are designed to prevent and treat arrhythmias associated with cardiac ischemia, ischemia-perfusion, and congestive heart failure. Additionally, he has developed methods and compositions for treating polycystic ovary syndrome (PCOS), which involve administering GLP-1 and its analogs to affected individuals.
Career Highlights
Throughout his career, Hathaway has worked with notable organizations such as Amylin Pharmaceuticals, Inc. and Indiana University. His work has significantly advanced the understanding and treatment of complex medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Hathaway has collaborated with esteemed colleagues, including Keith Leonard March and Robert L Wilensky. These partnerships have further enriched his research and development efforts, leading to innovative solutions in healthcare.
Conclusion
David R Hathaway's contributions to medical innovation, particularly in cardiac and reproductive health, highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving the lives of patients.